Barriers to patient enrolment in phase III cancer clinical trials: interviews with clinicians and pharmaceutical industry representatives

• Aniek Dane,
• P Hugo M van der Kuy,
• Soedaba Ashraf,
• James Timmis,
• Monique Bos,
• Carin Uyl-de Groot

Affiliations

Aniek Dane

Clinical Pharmacy, Erasmus MC, Rotterdam, The Netherlands

P Hugo M van der Kuy

Clinical Pharmacy, Erasmus MC, Rotterdam, The Netherlands

Soedaba Ashraf

Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

James Timmis

Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

Monique Bos

Internal Oncology, Erasmus MC Cancer Centre, Rotterdam, The Netherlands

Carin Uyl-de Groot

Erasmus School of Health Policy & Management, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands